share_log

正大企业国际(03839)附属拟购买一从事开发及生产中兽药公司大多数权益

CP International (03839) plans to purchase most of the rights and interests of a veterinary drug company engaged in development and production.

Zhitong Finance ·  May 11, 2022 20:19

Zhitong Financial APP News, CP International (03839) issued an announcement that on May 11, 2022, Pucheng CP, a non-wholly owned subsidiary of the company, signed a framework agreement with the target company and the controlling shareholders of the target company on the possible subscription and purchase of most of the rights and interests of the target company.

The target company is established in accordance with Chinese law, mainly engaged in the development and production of veterinary drugs.

Possible transactions are subject to, among other things, the satisfaction of Pucheng CP University with the due diligence results of the target company and the signing of the final agreement.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment